Jason Lettmann, Director, 10% Owner at ALX ONCOLOGY HOLDINGS INC (ALXO), bought 649,632 shares at $19.00 ($7.6M) on 2020-07-21, disclosed to the SEC on 2020-07-21.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $0.00 | 249,632 | $0 | 0.0% |
| 2 | $19.00 | 22,000 | $418K | 5.5% |
| 3 | $19.00 | 378,000 | $7.2M | 94.5% |
| Total | $11.70 avg | 649,632 | $7.6M | 100% |
| Filing → |
| ALXO | BUY | 2025-09-18 | $176K | — | Filing → |
| ALXO | SELL | 2025-08-19 | $2K | — | Filing → |
| ALXO | SELL | 2025-02-21 | $2K | — | Filing → |